204 related articles for article (PubMed ID: 23265095)
21. [Autologous stem cell therapy with surgical myocardial revascularization - The Rostock University experience].
Yerebakan C; Uğurlucan M; Kaminski A; Westphal B; Liebold A; Steinhoff G
Anadolu Kardiyol Derg; 2009 Dec; 9(6):457-64. PubMed ID: 19965315
[TBL] [Abstract][Full Text] [Related]
22. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial).
Mathiasen AB; Jørgensen E; Qayyum AA; Haack-Sørensen M; Ekblond A; Kastrup J
Am Heart J; 2012 Sep; 164(3):285-91. PubMed ID: 22980293
[TBL] [Abstract][Full Text] [Related]
23. Intraoperative CD133+ cell transplantation during coronary artery bypass grafting in ischemic cardiomyopathy.
Klein HM; Assmann A; Lichtenberg A; Heke M
Multimed Man Cardiothorac Surg; 2010 Jan; 2010(809):mmcts.2009.003947. PubMed ID: 24413679
[TBL] [Abstract][Full Text] [Related]
24. Long-term follow-up after autologous skeletal myoblast transplantation in ischaemic heart disease.
Brickwedel J; Gulbins H; Reichenspurner H
Interact Cardiovasc Thorac Surg; 2014 Jan; 18(1):61-6. PubMed ID: 24130088
[TBL] [Abstract][Full Text] [Related]
25. Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: a meta-analysis.
Donndorf P; Kundt G; Kaminski A; Yerebakan C; Liebold A; Steinhoff G; Glass A
J Thorac Cardiovasc Surg; 2011 Oct; 142(4):911-20. PubMed ID: 21376346
[TBL] [Abstract][Full Text] [Related]
26. Outcome after redo coronary artery bypass grafting in patients with ischaemic cardiomyopathy and viable myocardium.
Rizzello V; Poldermans D; Schinkel AF; Biagini E; Boersma E; Elhendy A; Sozzi FB; Palazzuoli A; Maat A; Crea F; Bax JJ
Heart; 2007 Feb; 93(2):221-5. PubMed ID: 16905627
[TBL] [Abstract][Full Text] [Related]
27. Intracoronary infusion of CD133+ and CD133-CD34+ selected autologous bone marrow progenitor cells in patients with chronic ischemic cardiomyopathy: cell isolation, adherence to the infarcted area, and body distribution.
Goussetis E; Manginas A; Koutelou M; Peristeri I; Theodosaki M; Kollaros N; Leontiadis E; Theodorakos A; Paterakis G; Karatasakis G; Cokkinos DV; Graphakos S
Stem Cells; 2006 Oct; 24(10):2279-83. PubMed ID: 16794269
[TBL] [Abstract][Full Text] [Related]
28. Intracoronary infusion of CD133+ endothelial progenitor cells improves heart function and quality of life in patients with chronic post-infarct heart insufficiency.
Flores-Ramírez R; Uribe-Longoria A; Rangel-Fuentes MM; Gutiérrez-Fajardo P; Salazar-Riojas R; Cervantes-García D; Treviño-Ortiz JH; Benavides-Chereti GJ; Espinosa-Oliveros LP; Limón-Rodríguez RH; Monreal-Puente R; González-Treviño JL; Rojas-Martínez A
Cardiovasc Revasc Med; 2010; 11(2):72-8. PubMed ID: 20347795
[TBL] [Abstract][Full Text] [Related]
29. The Athena trials: Autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction.
Henry TD; Pepine CJ; Lambert CR; Traverse JH; Schatz R; Costa M; Povsic TJ; David Anderson R; Willerson JT; Kesten S; Perin EC
Catheter Cardiovasc Interv; 2017 Feb; 89(2):169-177. PubMed ID: 27148802
[TBL] [Abstract][Full Text] [Related]
30. Intramyocardial Bone Marrow Stem Cells in Patients Undergoing Cardiac Surgical Revascularization.
Chan JL; Miller JG; Zhou Y; Robey PG; Stroncek DF; Arai AE; Sachdev V; Horvath KA
Ann Thorac Surg; 2020 Apr; 109(4):1142-1149. PubMed ID: 31526779
[TBL] [Abstract][Full Text] [Related]
31. Effect of direct intramyocardial autologous stem cell grafting in the sub-acute phase after myocardial infarction.
Laguna G; DI Stefano S; Maroto L; Fulquet E; Echevarría JR; Revilla A; Urueña N; Sevilla T; Arnold R; Ramos B; Gutiérrez H; Serrador A; San Román JA
J Cardiovasc Surg (Torino); 2018 Apr; 59(2):259-267. PubMed ID: 29582623
[TBL] [Abstract][Full Text] [Related]
32. Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery.
Chen S; Liu Z; Tian N; Zhang J; Yei F; Duan B; Zhu Z; Lin S; Kwan TW
J Invasive Cardiol; 2006 Nov; 18(11):552-6. PubMed ID: 17090821
[TBL] [Abstract][Full Text] [Related]
33. Transplantation of autologous bone marrow-derived cells into the myocardium of patients undergoing coronary bypass.
Oakley RE; Al msherqi Z; Lim SK; Lee SH; Ho KT; Sutandar A; Lee CN; Lim YT
Heart Surg Forum; 2005; 8(5):E348-50. PubMed ID: 16099737
[TBL] [Abstract][Full Text] [Related]
34. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up.
Dib N; Michler RE; Pagani FD; Wright S; Kereiakes DJ; Lengerich R; Binkley P; Buchele D; Anand I; Swingen C; Di Carli MF; Thomas JD; Jaber WA; Opie SR; Campbell A; McCarthy P; Yeager M; Dilsizian V; Griffith BP; Korn R; Kreuger SK; Ghazoul M; MacLellan WR; Fonarow G; Eisen HJ; Dinsmore J; Diethrich E
Circulation; 2005 Sep; 112(12):1748-55. PubMed ID: 16172284
[TBL] [Abstract][Full Text] [Related]
35. Revascularization in severe left ventricular dysfunction: outcome comparison of drug-eluting stent implantation versus coronary artery by-pass grafting.
Gioia G; Matthai W; Gillin K; Dralle J; Benassi A; Gioia MF; White J
Catheter Cardiovasc Interv; 2007 Jul; 70(1):26-33. PubMed ID: 17585381
[TBL] [Abstract][Full Text] [Related]
36. Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up.
Gavira JJ; Herreros J; Perez A; Garcia-Velloso MJ; Barba J; Martin-Herrero F; Cañizo C; Martin-Arnau A; Martí-Climent JM; Hernández M; López-Holgado N; González-Santos JM; Martín-Luengo C; Alegria E; Prósper F
J Thorac Cardiovasc Surg; 2006 Apr; 131(4):799-804. PubMed ID: 16580437
[TBL] [Abstract][Full Text] [Related]
37. Coronary artery bypass grafting with and without concomitant epicardial cardiac resynchronization therapy in patients with ischemic cardiomyopathy: a randomized study.
Pokushalov E; Romanov A; Prohorova D; Cherniavsky A; Karaskov A; Gersak B
Heart Surg Forum; 2010 Jun; 13(3):E177-84. PubMed ID: 20534420
[TBL] [Abstract][Full Text] [Related]
38. Myocardial blood flow and infarct size after CD133+ cell injection in large myocardial infarction with good recanalization and poor reperfusion: results from a randomized controlled trial.
Colombo A; Castellani M; Piccaluga E; Pusineri E; Palatresi S; Longari V; Canzi C; Sacchi E; Rossi E; Rech R; Gerundini P; Viecca M; Deliliers GL; Rebulla P; Soligo D; Giordano R
J Cardiovasc Med (Hagerstown); 2011 Apr; 12(4):239-48. PubMed ID: 21372740
[TBL] [Abstract][Full Text] [Related]
39. Autologous bone marrow cell transplantation combined with off-pump coronary artery bypass grafting in patients with ischemic cardiomyopathy.
Yoo KJ; Kim HO; Kwak YL; Kang SM; Jang YS; Lim SH; Hwang KC; Cho SW; Yang YS; Li RK; Kim BS
Can J Surg; 2008 Aug; 51(4):269-75. PubMed ID: 18815649
[TBL] [Abstract][Full Text] [Related]
40. Validating intramyocardial bone marrow stem cell therapy in combination with coronary artery bypass grafting, the PERFECT Phase III randomized multicenter trial: study protocol for a randomized controlled trial.
Donndorf P; Kaminski A; Tiedemann G; Kundt G; Steinhoff G
Trials; 2012 Jul; 13():99. PubMed ID: 22747980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
